%PDF-1.4
%
1 0 obj
<<
/AcroForm 2 0 R
/Metadata 3 0 R
/OpenAction 4 0 R
/Outlines 5 0 R
/Pages 6 0 R
/StructTreeRoot 7 0 R
/Type /Catalog
>>
endobj
8 0 obj
<<
/Author (EPAR, EU_2016-06-21bis_LOT1)
/CreationDate (D:20160622111643+03'00')
/Creator (Adobe Acrobat 6.0)
/Keywords (RCP PAS de BOITE)
/ModDate (D:20160622155609+02'00')
/Producer (Adobe Acrobat 6.0)
/Subject (h387n001)
/Title <414456414752414620302C35206D672C2067E96C756C657320E0206C6962E9726174696F6E2070726F6C6F6E67E9652C20323031362F30362F31362028736F75726365203D20455529>
>>
endobj
2 0 obj
<<
/DA (/Helv 0 Tf 0 g )
/DR 9 0 R
/Fields []
>>
endobj
3 0 obj
<<
/Length 10 0 R
/Subtype /XML
/Type /Metadata
>>
stream
2016-06-22T15:56:09+02:00
2016-06-22T11:16:43+03:00
2016-06-22T15:56:09+02:00
uuid:c598732d-f099-4606-924c-bf42a5cd6a1b
uuid:501cb01c-bf16-4814-a918-3dd3318730da
application/pdf
ADVAGRAF 0,5 mg, gélules à libération prolongée, 2016/06/16 (source = EU)
h387n001
EPAR, EU_2016-06-21bis_LOT1
RCP PAS de BOITE
RCP PAS de BOITE
endstream
endobj
4 0 obj
<<
/D [11 0 R /Fit]
/S /GoTo
>>
endobj
5 0 obj
<<
/Count 9
/First 12 0 R
/Last 12 0 R
/Type /Outlines
>>
endobj
6 0 obj
<<
/Count 36
/Kids [13 0 R 14 0 R 15 0 R]
/Type /Pages
>>
endobj
7 0 obj
<<
/K 16 0 R
/ParentTree 17 0 R
/ParentTreeNextKey 104
/RoleMap 18 0 R
/Type /StructTreeRoot
>>
endobj
9 0 obj
<<
/Encoding 19 0 R
/Font 20 0 R
>>
endobj
10 0 obj
3948
endobj
11 0 obj
<<
/Annots [21 0 R 22 0 R]
/Contents 23 0 R
/CropBox [0 0 612 792]
/Group 24 0 R
/MediaBox [0 0 612 792]
/Parent 25 0 R
/Resources 26 0 R
/Rotate 0
/StructParents 0
/Type /Page
>>
endobj
12 0 obj
<<
/Count 8
/First 27 0 R
/Last 27 0 R
/Parent 5 0 R
/Title (anx_135242_fr.pdf)
>>
endobj
13 0 obj
<<
/Count 18
/Kids [25 0 R 28 0 R 29 0 R 30 0 R]
/Parent 6 0 R
/Type /Pages
>>
endobj
14 0 obj
<<
/Count 5
/Kids [31 0 R]
/Parent 6 0 R
/Type /Pages
>>
endobj
15 0 obj
<<
/Count 13
/Kids [32 0 R 33 0 R 34 0 R]
/Parent 6 0 R
/Type /Pages
>>
endobj
16 0 obj
<<
/K [35 0 R 36 0 R]
/P 7 0 R
/S /Document
>>
endobj
17 0 obj
<<
/Kids [37 0 R 38 0 R]
>>
endobj
18 0 obj
<<
/Annotation /Span
/Chart /Figure
/Diagram /Figure
/DropCap /Figure
/Endnote /Note
/Footnote /Note
/InlineShape /Figure
/Outline /Span
/RB /Span
/RT /Span
/Ruby /Span
/Strikeout /Span
/Subscript /Span
/Superscript /Span
/TextBox /Art
/Underline /Span
>>
endobj
19 0 obj
<<
/PDFDocEncoding 39 0 R
>>
endobj
20 0 obj
<<
/Arial 40 0 R
/Helv 41 0 R
/ZaDb 42 0 R
>>
endobj
21 0 obj
<<
/AP 43 0 R
/BS 44 0 R
/Contents <414456414752414620302C35206D672C2067E96C756C657320E0206C6962E9726174696F6E2070726F6C6F6E67E9652C20323031362F30362F31362028736F75726365203D204555290D>
/CreationDate (D:20060912124156+02'00')
/DA (0 G 1 0.0361 0.0476 rg 0 Tc 0 Tw 100 Tz 0 TL 0 Ts 0 Tr /Arial 14 Tf)
/DS (font: Arial,sans-serif 14.0pt; text-align:center; color:#FF0000 )
/F 4
/M (D:20160622111941+03'00')
/NM (N0IBC1P_7GQIEBINTq9cfD)
/P 11 0 R
/Q 1
/RC (
ADVAGRAF 0,5 mg, gélules à libération prolongée, 2016/06/16 \(source = EU\)
)
/Rect [13.3314361572 710.311340332 383.5914611816 781.2903442383]
/Subj (Zone de texte )
/Subtype /FreeText
/T (karinegourand)
/Type /Annot
>>
endobj
22 0 obj
<<
/AP 45 0 R
/BS 46 0 R
/Contents (h387n001)
/CreationDate (D:20060912124156+02'00')
/DA (0 G 1 0.0361 0.0476 rg 0 Tc 0 Tw 100 Tz 0 TL 0 Ts 0 Tr /Arial 14 Tf)
/DS (font: Arial,sans-serif 14.0pt; text-align:center; color:#FF0000 )
/F 4
/M (D:20160622111755+03'00')
/NM (NNXrPllXbVgjqmRsaztHvB)
/P 11 0 R
/Q 1
/RC (h387n001
)
/Rect [487.5555725098 745.1516113281 601.8486938477 781.7838134766]
/Subj (Zone de texte )
/Subtype /FreeText
/T (karinegourand)
/Type /Annot
>>
endobj
23 0 obj
<<
/Filter /FlateDecode
/Length 47 0 R
>>
stream
H|Tmo0AؑJ҉@[Vهm SwNNBw~%./d#dp#,Bê>p(A+Q_]y4^;_PP=[^ p*ks^h(u6G?P1/-S\$:aq!6ILe.Q*fn}D0;Wjg`RroI~$)jf
"8Zu@
}PNzwZ ikh>N|vUP;.ls6g0$ef\:uϊ"~"ψ) s'!uRĽvhdڧз97v&5EXˈ^z0v+ -x y5gէAO^I